Abstract
Development of endoproteases, programmed to promote degradation of peptides or proteins responsible for pathogenic states, represents an attractive therapeutic strategy, since such biocatalytic agents could be directed against a potentially unlimited repertoire of extracellular proteinaceous targets. Difficulties associated with engineering enzymes with tailor-made substrate specificities have, however, hindered the discovery of proteases possessing both the efficiency and selectivity to act as therapeutics. Here, we disclose a genetic system, designed to report on site-specific proteolysis through the survival of a bacterial host, and the implementation of this method in the directed evolution of proteases with a non-native substrate preference. The high sensitivity potential of this system was established by monitoring the activity of the Tobacco Etch Virus protease (TEV-Pr) against co-expressed substrates of various recognition level and corroborated by both intracellular and cell-free assays. The genetic selection system was then used in an iterative mode with a library of TEV-Pr mutants to direct the emergence of proteases favoring a nominally poor substrate of the stringently selective protease. The retrieval of mutant enzymes displaying enhanced proteolytic properties against the non-native sequence combined with reduced recognition of the cognate hexapeptide substrate demonstrates the potential of this system for evolving proteases with improved or completely unprecedented properties.
Similar content being viewed by others
References
Vellard, M. (2003). The enzyme as drug: Application of enzymes as pharmaceuticals. Current Opinion in Biotechnology, 14, 444–450.
Christie, R. B. (1980). The medical uses of proteolytic enzymes. In A. Wiseman (Ed.), Topics in enzyme and fermentation biotechnology (pp. 25–113). Chichester: Ellis Horwood.
Chobotova, K., Vernallis, A. B., & Majid, F. A. A. (2010). Bromelain’s activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Letters, 290, 148–156.
Zhou, Y.-X., Karlee, S., Taguchi, H., Planque, S., Nishiyama, Y., & Paul, S. (2002). Prospects for immunotherapeutic proteolytic antibodies. Journal of Immunological Methods, 269, 257–268.
Kumar, J. K. (2008). Lysostaphin: An antistaphylococcal agent. Applied Microbiology and Biotechnology, 80, 555–561.
Uesugi, Y., Usuki, H., Iwabuchi, M., & Hatanaka, T. (2011). Highly potent fibrinolytic serine protease from Streptomyces. Enzyme and Microbial Technology, 48, 7–12.
Kurschus, F. C., & Jenne, D. E. (2010). Delivery and therapeutic potential of human granzyme B. Immunology Reviews, 235, 159–171.
Stenman, S. M., Venalainen, J. I., Lindfors, K., Auriola, S., Mauriala, T., Kaukovirta-Norja, A., Jantunen, A., Laurila, K., Qiao, S. W., Sollid, L. M., Mannisto, P. T., Kaukinen, K., & Maki, M. (2009). Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease. Annals of Medicine, 41, 390–400.
Pogson, M., Georgiou, G., & Iverson, B. L. (2009). Engineering next generation proteases. Current Opinion in Biotechnology, 20, 390–397.
Yuen, C. M., & Liu, D. R. (2007). Dissecting protein structure and function using directed evolution. Nature Methods, 4, 995–997.
Labrou, N. E. (2010). Random mutagenesis methods for in vitro directed enzyme evolution. Current Protein & Peptide, 11, 91–100.
Wang, T. W., Zhu, H., Ma, X. Y., Zhang, T., Ma, Y. S., & Wei, D. Z. (2006). Mutant library construction in directed molecular evolution: Casting a wider net. Molecular Biotechnology, 34, 55–68.
Jackel, C., & Hilvert, D. (2010). Biocatalysts by evolution. Current Opinion in Biotechnology, 21, 753–759.
Fernandez-Gacio, A., Uguen, M., & Fastrez, J. (2003). Phage display as a tool for the directed evolution of enzymes. Trends in Biotechnology, 21, 408–414.
Boersma, Y. L., Droge, M. J., & Quax, W. J. (2007). Selection strategies for improved biocatalysts. FEBS Journal, 274, 2181–2195.
Powell, K. A., Ramer, S. W., del Cardayre, S. B., Stemmer, W. P. C., Tobin, M. B., Longchamp, P. F., & Huisman, G. W. (2001). Directed evolution and biocatalysis. Angewandte Chemie International Edition, 40, 3948–3959.
Datta, S., Bucks, M. E., Koley, D., Lim, P. X., & Savinov, S. N. (2009). Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system. Bioorganic & Medicinal Chemistry, 18, 6099–6108.
Horswill, A. R., Savinov, S. N., & Benkovic, S. J. (2004). A systematic method for identifying small molecule modulators of protein–protein interactions. Proceedings of the National Academy of Sciences of the United States of America, 101, 15591–15596.
Miller, J. (1972). Experiments in molecular genetics. Cold Spring Harbor Laboratory: Cold Spring Harbor.
Platt, R., Drescher, C., Park, S. K., & Phillips, G. J. (2000). Genetic system for reversible integration of DNA constructs and lacZ gene fusions into the Escherichia coli chromosome. Plasmid, 43, 12–23.
Brakmann, S., & Lindemann, B. F. (2004). Generation of mutant libraries using random mutagenesis. In S. Brakmann & A. Schwienhorst (Eds.), Evolutionary methods in biotechnology: Clever tricks for directed evolution (pp. 5–11). Weinheim: Wiley-VCH Verlag Gmbh & Co. KgaA.
Cadwell, R. C., & Joyce, G. F. (1994). Mutagenic PCR. PCR Methods Applied, 3, S136–S140.
Cottier, V., Barberis, A., & Lüthi, U. (2006). Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format. Antimicrobial Agents and Chemotherapy, 50, 565–571.
Kim, S. Y., Park, K. W., Lee, Y. J., Back, S. H., Goo, J. H., Park, O. K., Jang, S. K., & Park, W. J. (2000). In vivo determination of substrate specificity of hepatitis C virus NS3 protease: Genetic assay for site-specific proteolysis. Analytical Biochemistry, 284, 42–48.
O’Loughlin, T. L., Greene, D. N., & Matsumura, I. (2006). Diversification and specialization of HIV protease function during in vitro evolution. Molecular and Biological Evolution, 23, 764–772.
Sices, H. J., & Kristie, T. M. (1998). A genetic screen for the isolation and characterization of site-specific proteases. Proceedings of the National Academy of Sciences of the United States of America, 95, 2828–2833.
Hu, J. C., Kornacker, M. G., & Hochschild, A. (2000). Escherichia coli one- and two-hybrid systems for the analysis and identification of protein–protein interactions. Methods, 20, 80–94.
Joung, J. K., Ramm, E. I., & Pabo, C. O. (2000). A bacterial two-hybrid selection system for studying protein–DNA and protein–protein interactions. Proceedings of the National Academy of Sciences of the United States of America, 97, 7382–7387.
Lallo, G. D., Castagnoli, L., Ghelardini, P., & Paolozzi, L. (2001). A two-hybrid system based on chimeric operator recognition for studying protein homo/heterodimerization in Escherichia coli. Microbiology, 147, 1651–1656.
Park, S.-H., & Raines, R. T. (2000). Genetic selection for dissociative inhibitors of designated protein–protein interactions. Nature Biotechnology, 18, 847–851.
Simoncsits, A., Chen, J., Percipalle, P., Wang, S., Törö, I., & Pongor, S. (1997). Single-chain repressors containing engineered DNA-binding domains of the phage 434 repressor recognize symmetric or asymmetric DNA operators. Journal of Molecular Biology, 267, 118–131.
van den Berg, S., Lofdahl, P. A., Hard, T., & Berglund, H. (2006). Improved solubility of TEV protease by directed evolution. Journal of Biotechnology, 121, 291–298.
Kostallas, G., & Samuelson, P. (2010). Novel fluorescence-assisted whole-cell assay for engineering and characterization of proteases and their substrates. Applied and Environmental Microbiology, 76, 7500–7508.
Khlebnikov, A., Datsenko, K. A., Skaug, T., Wanner, B. L., & Keasling, J. D. (2001). Homogeneous expression of the P(BAD) promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology, 147, 3241–3247.
Tong, L. (2002). Viral proteases. Chemical Reviews, 102, 4609–4626.
Seipelt, J., Guarne, A., Bergmann, E., James, M., Sommergruber, W., Fita, I., & Skern, T. (1999). The structures of picornaviral proteinases. Virus Research, 62, 159–168.
Mondigler, M., & Ehrmann, M. (1996). Site-specific proteolysis of the Escherichia coli SecA protein in vivo. Journal of Bacteriology, 178, 2986–2988.
Kapust, R. B., Tözsér, J., Fox, J. D., Anderson, D. E., Cherry, S., Copeland, T. D., & Waugh, D. S. (2001). Tobacco etch virus protease: Mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Engineering, 14, 993–1000.
Phan, J., Zdanov, A., Evdokimov, A. G., Tropea, J. E., Peters, H. K., III, Kapust, R. B., Li, M., Wlodawer, A., & Waugh, D. S. (2002). Structural basis for the substrate specificity of tobacco etch virus protease. Journal of Biological Chemistry, 277, 50564–50572.
Kapust, R. B., Tözsér, J., Copeland, T. D., & Waugh, D. S. (2002). The P1′ specificity of tobacco etch virus protease. Biochemical and Biophysical Research Communication, 294, 949–955.
Haldimann, A., & Wanner, B. L. (2001). Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure–function studies of bacteria. Journal of Bacteriology, 183, 6384–6393.
Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C., & Benkovic, S. J. (1999). Production of cyclic peptides and proteins in vivo. Proceedings of the National Academy of Sciences of the United States of America, 96, 13638–13643.
Verhoeven, K.D. (2011) Genetic system for detecting, monitoring, and evolving site-specific proteases: Development of therapeutic proteases targeting amyloid-beta peptide, Ph.D. Thesis, Purdue University, West Lafayette.
Arenkov, P., Kukhtin, A., Gemmell, A., Voloshchuk, S., Chupeeva, V., & Mirzabekov, A. (2000). Protein microchips: Use for immunoassay and enzymatic reactions. Analytical Biochemistry, 278, 123–131.
Puhl, A. C., Giacomini, C., Irazoqui, G., Batista-Viera, F., Villarino, A., & Terenzi, H. (2009). Covalent immobilization of tobacco-etch-virus NIa protease: A useful tool for cleavage of the histidine tag of recombinant proteins. Biotechnology and Applied Biochemistry, 53, 165–174.
Xie, W. L., & Ma, N. (2010). Enzymatic transesterification of soybean oil by using immobilized lipase on magnetic nano-particles. Biomass and Bioenergy, 34, 890–896.
Acknowledgments
The authors would like to thank B. L. Wanner (Purdue University, West Lafayette, Indiana) for donation of strains and plasmids. This study was sponsored by the National Institutes of Health (grant number: 1R21AG031437-01).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM. 1
(DOC 1239 kb)
Rights and permissions
About this article
Cite this article
Verhoeven, K.D., Altstadt, O.C. & Savinov, S.N. Intracellular Detection and Evolution of Site-Specific Proteases Using a Genetic Selection System. Appl Biochem Biotechnol 166, 1340–1354 (2012). https://doi.org/10.1007/s12010-011-9522-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-011-9522-6